release of keytruda/LL data - when cytodyn agreed to the study, do they not have the right to see the data?
4. MERCK KEYTRUDA/LL results in CRC ...SP goes up
The results almost certainly showed that leronlimab alone was as effective as a leronlimab/checkpoint inhibitor combo without the nasty side effects of the checkpoint inhibitor. Whomever the company was that sponsored that study will never release those findings.
Read More: https://investorshangout.com/post/newpost/605...z8JHse7gg8